Article Text

Download PDFPDF

Original article
Systematic literature review of domains assessed in psoriatic arthritis to inform the update of the psoriatic arthritis core domain set
  1. Umut Kalyoncu1,2,
  2. Alexis Ogdie3,
  3. Willemina Campbell4,
  4. Clifton O Bingham III1,
  5. Maarten de Wit5,
  6. Dafna D Gladman6,
  7. Philip Mease7,
  8. Ingrid Steinkoenig8,
  9. Vibeke Strand9,
  10. Victoria G Riese1,10 and
  11. Ana-Maria Orbai1
  1. 1Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA
  2. 2Division of Rheumatology, Hacettepe University, Ankara, Turkey
  3. 3University of Pennsylvania, Philadelphia, Pennsylvania, USA
  4. 4Patient Research Partner, Toronto, Ontario, Canada
  5. 5Department of Medical Humanities, Patient Research Partner, VU University Medical Centre, Amsterdam, The Netherlands
  6. 6Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada
  7. 7Swedish Medical Center and University of Washington, Seattle, Washington, USA
  8. 8Patient Research Partner, Cleveland, Ohio, USA
  9. 9Division of Immunology, Stanford University, Palo Alto, California, USA
  10. 10National Institutes of Health Library, Education Services Branch, Bethesda, Maryland, USA
  1. Correspondence to Dr Ana-Maria Orbai; aorbai1{at}jhmi.edu

Abstract

The objectives of this systematic literature review (SLR) were to identify domains and outcome measures used in psoriatic arthritis (PsA) studies in the past 5 years, and to compare the measurement of the Outcome Measures in Rheumatology (OMERACT) 2006 PsA Core Domain Set in studies published in 2010–2015 vs those published in 2006–2010. We performed a systematic literature search in two databases, PubMed and Embase, to identify randomised controlled trials (RCTs) in PsA. We also identified PsA longitudinal observational studies (LOS). Three patient research partners provided input into study conception, and data collection and interpretation. We identified 41 studies representing 22 unique RCTs, 27 LOS and 12 registries. Across all studies, we identified 24 domains and 169 outcome measures. In addition to the PsA Core Domain Set (6 domains), the following domains were also assessed in more than 30% of RCTs: acute phase reactants, dactylitis, enthesitis, fatigue and work productivity. We identified a range of 1–15 outcome measures per domain with a mean (SD) of 7 (4.7) per domain. The complete PsA Core Domain Set was assessed in 59% of RCTs in 2010–2015 compared to 23.5% RCTs in 2006–2010. There has been increased measurement of the PsA Core Domain Set in RCTs and LOS in the past 5 years. Numerous additional outcomes were also measured. The PsA Core Domain Set needs an update to standardise PsA outcome assessments. This SLR will inform the development of an updated PsA Core Domain Set with patient research partner input.

  • Psoriatic Arthritis
  • Outcomes research
  • Health services research

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.